Free Trial

Tristel (TSTL) Competitors

Tristel logo
GBX 399 -5.00 (-1.24%)
As of 01/21/2025 11:25 AM Eastern

TSTL vs. AMS, BVC, SPEC, AKR, CNSL, ODX, CTEC, CRW, ERGO, and CSRT

Should you be buying Tristel stock or one of its competitors? The main competitors of Tristel include Advanced Medical Solutions Group (AMS), BATM Advanced Communications (BVC), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Craneware (CRW), Ergomed (ERGO), and Consort Medical plc (CSRT.L) (CSRT). These companies are all part of the "medical" sector.

Tristel vs.

Tristel (LON:TSTL) and Advanced Medical Solutions Group (LON:AMS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, community ranking, institutional ownership, valuation, dividends and profitability.

In the previous week, Tristel and Tristel both had 1 articles in the media. Tristel's average media sentiment score of 1.11 beat Advanced Medical Solutions Group's score of 0.84 indicating that Tristel is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tristel
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Advanced Medical Solutions Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tristel has a net margin of 15.29% compared to Advanced Medical Solutions Group's net margin of 8.49%. Tristel's return on equity of 20.35% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.29% 20.35% 9.89%
Advanced Medical Solutions Group 8.49%4.59%2.35%

Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.3%. Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 0.9%. Tristel pays out 10,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 4,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Advanced Medical Solutions Group has a consensus target price of GBX 300, indicating a potential upside of 38.25%. Given Advanced Medical Solutions Group's stronger consensus rating and higher possible upside, analysts plainly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tristel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Advanced Medical Solutions Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Advanced Medical Solutions Group received 18 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 50.00% of users gave Advanced Medical Solutions Group an outperform vote.

CompanyUnderperformOutperform
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%
Advanced Medical Solutions GroupOutperform Votes
166
50.00%
Underperform Votes
166
50.00%

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£39.49M4.81£6.04M£0.133,069.23
Advanced Medical Solutions Group£131.11M3.55£11.13M£0.054,340.00

Tristel has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Advanced Medical Solutions Group has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500.

50.4% of Tristel shares are held by institutional investors. Comparatively, 58.2% of Advanced Medical Solutions Group shares are held by institutional investors. 4.9% of Tristel shares are held by company insiders. Comparatively, 3.1% of Advanced Medical Solutions Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Advanced Medical Solutions Group beats Tristel on 10 of the 19 factors compared between the two stocks.

Get Tristel News Delivered to You Automatically

Sign up to receive the latest news and ratings for TSTL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TSTL vs. The Competition

MetricTristelMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£190.12M£2.88B£5.40B£2.04B
Dividend Yield3.59%2.01%5.37%5.16%
P/E Ratio3,069.23341.0888.971,926.65
Price / Sales4.81161.051,285.79384,006.48
Price / Cash20.96146.5436.6029.21
Price / Book6.052.954.963.08
Net Income£6.04M£91.96M£117.96M£183.60M
7 Day Performance2.31%1.79%2.58%3.09%
1 Month Performance-0.25%3.00%3.53%3.42%
1 Year Performance-5.00%-4.42%27.05%165.41%

Tristel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TSTL
Tristel
N/AGBX 399
-1.2%
N/A-5.0%£190.12M£39.49M3,069.23208Gap Down
AMS
Advanced Medical Solutions Group
2.2273 of 5 stars
GBX 190.60
flat
GBX 300
+57.4%
+4.8%£408.93M£131.11M3,812.0010
BVC
BATM Advanced Communications
N/AGBX 18.56
+0.6%
N/A-22.5%£80.97M£122.70M2,800.00980Gap Down
SPEC
INSPECS Group
N/AGBX 42
+5.5%
N/A-56.5%£42.70M£195.14M-13.681,673Gap Up
High Trading Volume
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 3.06
+0.4%
N/A+58.0%£7.28M£9.77M-362.103,200News Coverage
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
2.6624 of 5 stars
GBX 226.80
+1.2%
GBX 301.67
+33.0%
-1.8%£4.65B£2.20B3,780.0010,000News Coverage
CRW
Craneware
1.9719 of 5 stars
GBX 2,146.78
+5.0%
GBX 2,700
+25.8%
+3.6%£758.67M£189.27M8,256.83734High Trading Volume
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386News Coverage
CSRT
Consort Medical plc (CSRT.L)
N/AN/AN/AN/A£504.60M£298.60M127.85N/A

Related Companies and Tools


This page (LON:TSTL) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners